Atropine Sulfate/Edrophonium Chloride

硫酸阿托品/依酚氯铵

Report date: 2026/05/24 20:00:34

Base Information

Drug NameAtropine Sulfate/Edrophonium Chloride
Drug Alias NameEdrophonium Chloride-Atropine Sulfate依酚氯铵-硫酸阿托品混合物Edrophonium Chloride-Atropine Sulfate mixtAtropine Sulfate and Edrophonium ChlorideEdrophonium Chloride and Atropine Sulfate +[6] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAcetylcholinesterase inhibitorsMuscle relaxation antagonists
TargetsMuscarinic acetylcholine receptorAcetylcholinesterase
Therapy Area/IndicationsNeuromuscular Blockade
Global Approved IndicationsNeuromuscular Blockade
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1991/11/06
Country/TerritoryUnited States
CombinationsYes Edrophonium ChlorideAtropine Sulfate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmobedient Consulting LLC
Active IndicationsN/A
Inactive IndicationsNeuromuscular Blockade

Other Information

ATC CodeN/A
Related LinksN/A